Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Important Economic News Calendar: November 11 – November 15, 2019

Last week the markets took some breather following the late October - early November huge economic data announcements. The ISM Non-Manufacturing PMI led to some volatility but despite the sell-off in gold it was a relatively quiet week on the financial markets. What about the ...

Market News Report: December 9 – December 13, 2019

Last week’s economic data releases brought volatility to the financial markets. Stocks sold off following worse-than-expected PMI readings, then they got back up after Friday’s huge Nonfarm payrolls beat. The price of gold rallied and then sold ...

Stocks to Watch: DynaCERT Inc. poised for exponential move

The level of interest for dynaCERT’s award winning HydraGEN (HG) technology is building globally as a solution to the problem of harmful exhaust emissions plaguing cities across the world. It appears only a matter of time before the demand growth cu...

Fed’s Cut Puzzle and Gold

At the end of July, the Fed trimmed the federal funds rate . However, the dovish U-turn within the FOMC amid solid US economy remains a mystery. We invite you to read our today’s article about the Fed’s cut puzzle and its find out what do...

Biogen Shares Rebound Strongly on Updated Phase 3 Alzheimer's Data and Q3 Earnings

Shares of Biogen Inc. opened nearly 39% higher today after the firm announced plans to submit a Biologics License Application to the FDA in early 2020 for its Alzheimer's drug aducanumab based on new analysis of larger datasets from two phase 3 studies. The company also anno...

The Last Hawk Flew to Heaven

Sad moment. Paul Volcker, the former Fed Chairman went to Bank of Heaven. We are not reporting this news due to the implications for gold prices, but as an opportunity to reflect on changes in the central banking since the time of Tall Paul and on their consequences for the go...

Arbutus Biopharma Trades 25% Higher on Phase 1 Hepatitis B Results

Shares of Arbutus Biopharma traded higher after the company reported significant and continuous reduction in HBsAg in 12 chronic hepatitis B subjects using 60 mg dosage of its AB-729 drug. Clinical-stage biopharmaceutical company Arbutus Biopharma Corp. (ABUS:NASD...

Diagnos increases footprint, and endorsements mount for AI tech that averts illness

Applying Artificial Intelligence (AI) for early detection tests of vascular change in the retina, targeting the diabetes market for vision loss prevention & soon cardiovascular disease. Valuation and Assumptions: Based on due diligence and valuation estimates, Mar...

Buzz on the Bullboards: ‘Till debt do us party

These last few weeks markets across the globe have been swaying up and down. Looking at media headlines, are we about to see a full recovery of the global economy … or is more trouble ahead? Data showed that consumer inflation unexpectedly accelerated in April, th...

dynaCERT $3/share Target, The New Green Deal for Carbon Emission Reduction Technology

Market Equities Research Group has issued a near-term (12 month) price target for dynaCERT Inc. (TSX-V: DYA) of C$3/share. The stock market is a forward discounting mechanism; share prices are apt to rise quickly as future prospects brighten. Investors seeking high...
1 2 3 4 5